rs140116256
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001122752.2(SERPINI1):āc.432T>Cā(p.Asn144=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,613,888 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0010 ( 1 hom., cov: 32)
Exomes š: 0.0014 ( 6 hom. )
Consequence
SERPINI1
NM_001122752.2 synonymous
NM_001122752.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.308
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-167790553-T-C is Benign according to our data. Variant chr3-167790553-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 344128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-167790553-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.308 with no splicing effect.
BS2
High AC in GnomAd4 at 159 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINI1 | NM_001122752.2 | c.432T>C | p.Asn144= | synonymous_variant | 3/9 | ENST00000446050.7 | NP_001116224.1 | |
SERPINI1 | NM_005025.5 | c.432T>C | p.Asn144= | synonymous_variant | 3/9 | NP_005016.1 | ||
SERPINI1 | XM_017006618.3 | c.432T>C | p.Asn144= | synonymous_variant | 3/9 | XP_016862107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINI1 | ENST00000446050.7 | c.432T>C | p.Asn144= | synonymous_variant | 3/9 | 1 | NM_001122752.2 | ENSP00000397373 | P1 | |
SERPINI1 | ENST00000295777.9 | c.432T>C | p.Asn144= | synonymous_variant | 3/9 | 1 | ENSP00000295777 | P1 | ||
SERPINI1 | ENST00000472747.2 | c.432T>C | p.Asn144= | synonymous_variant | 3/5 | 3 | ENSP00000420561 | |||
SERPINI1 | ENST00000472941.5 | c.432T>C | p.Asn144= | synonymous_variant | 3/3 | 3 | ENSP00000420133 |
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 159AN: 152232Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
159
AN:
152232
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000928 AC: 233AN: 251074Hom.: 0 AF XY: 0.00105 AC XY: 142AN XY: 135680
GnomAD3 exomes
AF:
AC:
233
AN:
251074
Hom.:
AF XY:
AC XY:
142
AN XY:
135680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00144 AC: 2106AN: 1461656Hom.: 6 Cov.: 31 AF XY: 0.00140 AC XY: 1016AN XY: 727122
GnomAD4 exome
AF:
AC:
2106
AN:
1461656
Hom.:
Cov.:
31
AF XY:
AC XY:
1016
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00104 AC: 159AN: 152232Hom.: 1 Cov.: 32 AF XY: 0.000941 AC XY: 70AN XY: 74378
GnomAD4 genome
AF:
AC:
159
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
70
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | SERPINI1: BP4, BP7 - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Familial encephalopathy with neuroserpin inclusion bodies Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at